[1]
A. H. Sinaga, M. Zebua, G. Berlian, and A. Aripin, “Pharmacoeconomic Evaluation and Clinical Outcomes of Channa as an Adjuvant to 20% Human Albumin Therapy in Patients with Chronic Kidney Disease: A Cost-Effectiveness Analysis (CEA) at Imelda Pekerja Indonesia General Hospital”, JU-TI, vol. 5, no. 01, pp. 178–187, Aug. 2026.